Presentations to Detail Latest Cardiac Surgery Technology to be Held January 26th at 6:30 p.m. Eastern Time FORT LAUDERDALE, Fla., Jan. 15 /PRNewswire-FirstCall/ -- Five leading medical...
SOPHIA ANTIPOLIS, France, May 11 /PRNewswire-FirstCall/ -- NicOx S.A. (Eurolist: COX) today provided an update on the phase 2a study for NCX 1000, which is covered by its codevelopment agreement...
Integrated Commercial and Government Applications Will Improve Speed and Accuracy of Revenue Management Processes SOUTH SAN FRANCISCO, Calif., June 22 /PRNewswire/ -- Model N, Inc., the pioneer...
TSX SYMBOL (Toronto Stock Exchange): AXP NASDAQ SYMBOL (NASDAQ National Market): AXCA MONT-SAINT-HILAIRE, QC, May 10 /PRNewswire-FirstCall/ -- Axcan Pharma Inc...
MONT-SAINT-HILAIRE, QC, May 4 /PRNewswire-FirstCall/ -- AXCAN PHARMA INC. Consolidated Balance Sheets (in thousands of U.S. dollars, except share related data) March September 31...
TSX SYMBOL (Toronto Stock Exchange): AXP NASDAQ SYMBOL (NASDAQ National Market): AXCA MONT-SAINT-HILAIRE, QC, May 4 /PRNewswire-FirstCall/ -- Axcan Pharma Inc. (NASDAQ:AXCANASDAQ:-NASDAQ:TSX:NASDA...
TSX SYMBOL (Toronto Stock Exchange): AXP NASDAQ SYMBOL (Nasdaq National Market): AXCA MONT-SAINT-HILAIRE, QC, April 24 /PRNewswire-FirstCall/ -- Axcan Pharma Inc. ("Axcan" or the "Company...
TSX SYMBOL (Toronto Stock Exchange): AXP NASDAQ SYMBOL (NASDAQ National Market): AXCA MONT-SAINT-HILAIRE, QC, April 19 /PRNewswire-FirstCall/ -- Axcan Pharma Inc. ("Axcan" or the "Company...
TSX SYMBOL (Toronto Stock Exchange): AXP NASDAQ SYMBOL (NASDAQ National Market): AXCA MONT SAINT-HILAIRE, April 18 /PRNewswire-FirstCall/ -- Axcan Pharma Inc. ("Axcan" or the "Company") today...
TSE SYMBOL (Toronto Stock Exchange): AXP NASDAQ SYMBOL (NASDAQ National Market): AXCA MONT-SAINT-HILAIRE, QC, March 29 /PRNewswire-FirstCall/ -- Axcan Pharma Inc...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約